BDBM664618 (2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6- ((4-(3-ethyloxetan-3-yl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5- methoxytetrahydro-2H-pyran-3-ol::US20240109930, Example 1.2.38.

SMILES CCC1(COC1)c1cn(C[C@H]2O[C@H](CO)[C@H](O)[C@@H]([C@H]2OC)n2cc(nn2)-c2ccc(C)c(F)c2F)nn1

InChI Key InChIKey=RRYFWGVZACFJMZ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 664618   

TargetGalectin-3(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM664618(US20240109930, Example 1.2.38. | (2R,3R,4S,5R,6R)-...)
Affinity DataIC50: 30nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384well plates are supplemented with 22.8 μL/well of biotinylate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
US Patent

TargetGalectin-1(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM664618(US20240109930, Example 1.2.38. | (2R,3R,4S,5R,6R)-...)
Affinity DataIC50: 2.65E+3nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384well plates are supplemented with 22.8 μL/well of biotinylate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
US Patent